HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Liver Cancer

Liver Cancer

Liver cancer, especially hepatocellular carcinoma (HCC), poses a significant health challenge worldwide. Recent strides in cancer research are revolutionizing its diagnosis and treatment. Advances in genomic profiling are uncovering critical molecular mechanisms, paving the way for tailored therapies. Immunotherapy, particularly with immune checkpoint inhibitors, is showing encouraging results by boosting the body's immune response against cancer cells. Additionally, innovative imaging techniques are enhancing the early detection and monitoring of liver tumors. Researchers are also investigating combination therapies that merge traditional methods like surgery and chemotherapy with new treatments to achieve better outcomes. Ongoing research is vital to fully understand liver cancer and develop more effective, targeted therapies.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Atif A Ahmed

Atif A Ahmed

Seattle Children’s Hospital, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
CIOC 2027 Speakers
Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Saumya Pandey

Saumya Pandey

Indira IVF Hospital, India

Submit your abstract Today

YouTube
WhatsAppWhatsApp